Page 8 - 03- Barrett Esophagus
P. 8
intramucosal cancer. Gastrointest Endosc. 2018;87(4):907–931.e9.
ADDITIONAL READING
Dunbar KB, Spechler SJ. Controversies in Barrett esophagus. Mayo Clin Proc.
2014;89(7):973–984.
Zimmerman TG. Common questions about Barrett esophagus. Am Fam Physician.
2014;89(2):92–98.
CODES
ICD10
K22.70 Barrett’s esophagus without dysplasia
K22.719 Barrett’s esophagus with dysplasia, unspecified
K22.710 Barrett’s esophagus with low grade dysplasia
CLINICAL PEARLS
The incidence of esophageal cancer is rising faster than any other major malignancy. BE is a
precursor to esophageal carcinoma.
The highest incidence of BE is in white males >50 years of age.
Endoscopic eradication therapy is preferred for dysplasia with or without submucosal invasion.
Esophagectomy is generally limited to patients with invasive carcinoma or those failing to
respond to endoscopic therapy.
